StockData
Niagen Bioscience, Inc. logo

Niagen Bioscience, Inc. (NAGE) stock

NAGENasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3013% below fair value
$2.01−0.06 (-2.66%)

Close on Nov 16, 2026Market cap $159.04MP/E 16.8Yield –

Niagen Bioscience ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2018 it was -$32.57M. The highest annual figure on record is -$1.78M in fiscal 2015.

Annual ebitda

PeriodPeriod endValueChange
FY2018Dec 31, 2018-$32.57M–
FY2017Dec 30, 2017-$15.87M–
FY2016Dec 31, 2016-$2.57M–
FY2015Jan 2, 2016-$1.78M–
FY2014Jan 3, 2015-$5.01M–
FY2013Dec 28, 2013-$4.14M–

More Niagen Bioscience figures

See a number that looks wrong?